This provides a rationale to incorporate 24,25(OH)2D measurement in assessing VitD status—especially, to differentiate patients with secondary hyperparathyroidism from patients with subclinical VitD deficiency but normal PTH levels. Here, PTH is linked to secondary hyperparathyroidism.